A genome-wide screen for nicotine dependence susceptibility loci
Genome‐wide model free linkage analysis was conducted for nicotine dependence and tobacco use phenotypes in 607 members of 158 nuclear families consisting of at least two ever smokers (100 or more cigarettes smoked in lifetime). DNA from whole blood was genotyped for 739 autosomal microsatellite pol...
Saved in:
Published in | American journal of medical genetics. Part B, Neuropsychiatric genetics Vol. 141B; no. 4; pp. 354 - 360 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
05.06.2006
Wiley-Liss |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Genome‐wide model free linkage analysis was conducted for nicotine dependence and tobacco use phenotypes in 607 members of 158 nuclear families consisting of at least two ever smokers (100 or more cigarettes smoked in lifetime). DNA from whole blood was genotyped for 739 autosomal microsatellite polymorphisms with an average inter‐marker distance of 4.6 cM. A peak LOD score of 2.7 was observed on chromosome 6 for scores for the Fagerström Test for Nicotine Dependence. Exploratory analyses were conducted to determine whether sequence variation at other loci affected other measures of dependence or tobacco use. Four additional loci with LOD scores of 2.7 or more were associated with alternative measures of nicotine dependence, one with current frequency of use, and one with smoking cessation. Several of the corresponding support intervals were near putative loci reported previously (on chromosomes 6, 7, and 8) while others appear to be novel (on chromosomes 5, 16, and 19). © 2006 Wiley‐Liss, Inc. |
---|---|
Bibliography: | Funds from the State of California for medical research on alcohol and substance abuse through the Department of Neurology of University of California at San Francisco Gary E. Swan, Hyman Hops, and Kirk C. Wilhelmsen contributed equally to the conduct of this research. The National Institute of Drug Abuse - No. DA03706 istex:3A8191A3AD6A01F43B8FFC92FB537142AAA9A636 The University of California Tobacco-Related Diseases Research Program - No. 7PT2000, 2001, 2002, 2003, 2004 ArticleID:AJMG30315 ark:/67375/WNG-95D40LNG-R Please cite this article as follows: Swan GE, Hops H, Wilhelmsen KC, Lessov-Schlaggar CN, Cheng LS-C, Hudmon KS, Amos CI, Feiler HS, Ring HZ, Andrews JA, Tildesley E, Benowitz N. 2006. A Genome-Wide Screen for Nicotine Dependence Susceptibility Loci. Am J Med Genet Part B 141B:354-360. Please cite this article as follows: Swan GE, Hops H, Wilhelmsen KC, Lessov‐Schlaggar CN, Cheng LS‐C, Hudmon KS, Amos CI, Feiler HS, Ring HZ, Andrews JA, Tildesley E, Benowitz N. 2006. A Genome‐Wide Screen for Nicotine Dependence Susceptibility Loci. Am J Med Genet Part B 141B:354–360. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These three authors contributed equally to the conduct of this research. Current affiliation for KCW: Department of Genetics and Neurology, University of North Carolina, Chapel Hill; KSH: Department of Epidemiology and Public Health, Yale University School of Medicine; HSF: Department of Laboratory Medicine, University of California San Francisco and Lawrence Berkeley National Laboratory |
ISSN: | 1552-4841 1552-485X |
DOI: | 10.1002/ajmg.b.30315 |